In this second part, RV Radio continues the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day business and finding investment funding.
[Audio Interview] ThinkGenetic Leadership Team Interview with RV Radio Part 1
The ThinkGenetic leadership team was recently interviewed for the RV Radio podcast with Cian Robinson, discussing the origin of ThinkGenetic while giving insight into what it’s like to be diagnosed with a genetic condition later in life when doctors are stumped and existing tools to diagnose are limited.
[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
New Research to be Presented at AAAAI 2022 on Hereditary Angioedema
ThinkGenetic is proud to announce a recent collaborative research project will be presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting this February 25-29th in […]
[Press Release] Massachusetts Startup Wins Horizon Prize, Powered by MIT Solve, with Algorithm-Based FindEHR Solution for Finding Undiagnosed Genetic Disorder Patients using Electronic Medical Records
ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA, […]
[Press Release] Horizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis
Horizon Therapeutics plc (Nasdaq: HZNP), in collaboration with MIT Solve, a marketplace for social impact innovation, is proud to announce two winning solutions of this year’s Horizon Prize, ThinkGenetic Inc. and Congenica.
[Press Release] Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients
ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.
[Press Release] ThinkGenetic Closes $1.5M Angel Round of Funding
ThinkGenetic, Inc., makers of an artificial intelligence-driven SymptomMatcher™ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M.
ThinkGenetic Father Hopes to Revolutionize Genetic Information on the Internet
Like many other people with a genetic disease, Dave Jacob did not learn that his childhood heart defect was related to an underlying genetic mutation until it was uncovered he […]
